Google scholar boris pasche
WebDec 19, 2014 · Boris Pasche Wake Forest Baptist Comprehensive Cancer Center and Department of Cancer Biology. Professor, Department of Cancer Biology and Section of … WebBoris C. Pasche, MD, PhD serves as Chairman of the Board of Directors and Chief Executive Officer of the Company. He is the co-founder of TheraBionic Inc., formerly TheraBionic LLC and TheraBionic GmbH, companies focused on the commercialization of the TheraBionic device for the systemic treatment of cancer.
Google scholar boris pasche
Did you know?
WebBoris Pasche. The UAB Comprehensive Cancer Center, Division of Hematology/Oncology, The University of Alabama at Birmingham, Birmingham, USA. View editor publications. … Web15. 13. i10-index. 22. 15. Natacha Tofield-Pasche. Deputy Director of the Limnology Center, EPFL. Verified email at epfl.ch - Homepage. limnology biogeochemistry carbon nutrients lake.
WebRole: Principal Investigator. R01CA112520 (PASCHE, BORIS) Dec 1, 2004 - Jul 31, 2014. NIH. TGF-beta polymorphisms and breast cancer in families. Role: Principal Investigator. R01CA108741 (PASCHE, BORIS) Feb 24, 2006 - Jan 31, 2010. NIH. TGF-beta pathway polymorphisms and colon cancer risk. Role: Principal Investigator. WebApr 15, 2007 · Google Scholar. Boris Pasche. Boris Pasche * Cancer Genetics Program, Division of Hematology/Oncology, Department of Medicine and Robert H. Lurie …
WebThis "Cited by" count includes citations to the following articles in Scholar. The ones marked * may be different from the article in the profile. Add co-authors Co-authors. Follow. New articles by this author. New citations to this author. New articles related to this author's research. Email address for updates. WebJan 16, 2001 · The finding of TβR-I(6A) overrepresentation among patients with a diagnosis of cancer is corroborated by two other studies (Pasche et al., 1999; Chen et al., 1999). One study conducted on US and Jamaican residents assessed TβR-I(6A) frequency among 66 patients with a diagnosis of cancer of the cervix and 64 matched controls (Chen et al., …
WebThe major parts of my research agenda are linked above. You can find my Google Scholar citations here, and my SSRN page here (with my working papers). Visit the American …
WebSep 15, 2024 · “HCC accounts for nearly 90% of all liver cancers, and current survival rates are between six and 20 months,” said Dr. Boris Pasche, chair of cancer biology at Wake Forest School of Medicine ... shop wsopWebUsing patient-based discovery methods (Pasche, Jimenez et al. 2015), we have pioneered the use of low levels amplitude-modulated radiofrequency electromagnetic fields as a … shopwss raffleWebKeywords. Breast Cancer; Breast Cancer Risk; Transform Growth Factor Beta; Mammary Gland Development; Transform Growth Factor Beta Receptor; These keywords were added by machine and not by the authors. shopwss near meWebProfessor Boris C. Pasche is Chairman of the Board and CEO of TheraBionic Inc. and Geschäftsführer of TheraBionic GmbH. He is coinventor of the TheraBionic technology, cofounder of TheraBionic Inc., formerly TheraBionic LLC, and TheraBionic GmbH, companies focused on the commercialization of TheraBionic’s novel technology for the … shopwss redditWebDec 14, 2009 · Google Scholar. Qinghua Zeng; Qinghua Zeng 1 Department of Surgery and 2 Cancer Genetics Program, Division ... Chicago, IL 60611. Phone: 312-503-0732; … shopwss printable couponWebMar 2, 2024 · Fei Xing, Michael Chan, Jimmy Ruiz, Linda J. Metheny-Barlow, Roy Strowd, Boris Pasche, Waldemar Debinski, Kounosuke Watabe & Hui-Wen Lo ... You can also … sanding after staining to lightenWebJan 16, 2001 · The finding of TβR-I(6A) overrepresentation among patients with a diagnosis of cancer is corroborated by two other studies (Pasche et al., 1999; Chen et al., 1999). … shopwss promotional codes